Novavax, Inc. (NVAX) market cap

Market cap today
$1.31B

Novavax, Inc. (NVAX) has a market cap of $1.31B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.16B. That is 4.9% lower than the $1.22B of fiscal 2024. Today's figure is 12.9% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$1.31B
Market cap, fiscal 2025
$1.16B
Change on fiscal 2024
−4.9%
Growth, 5 years
−28.9% a year
Highest on record
$10.64Bfiscal 2021
Lowest on record
$95.92Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novavax, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 28.9% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $10.64B in fiscal 2021 and the lowest $95.92M in fiscal 2019.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Novavax, Inc. market cap, year by year

Novavax, Inc. (NVAX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$1.31B—$7.96—
2025$1.16B 4.9% down$6.72173.10M
2024$1.22B 153.0% up$8.04152.19M
2023$483.69M 39.8% down$4.80100.77M
2022$803.72M 92.4% down$10.2878.18M
2021$10.64B 65.9% up$143.0774.40M
2020$6.42B 6,591.0% up$111.5157.55M
2019$95.92M—$3.9824.10M
2018——$36.80—
2017——$24.80—
2016——$25.20—
2015——$167.80—
2014——$118.60—
2013——$102.40—
2012——$37.80—
2011——$25.20—
2010——$48.60—
2009——$53.20—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on NVAX

Novavax, Inc., figure by figure

Novavax, Inc. (NVAX) overview: price, valuation and scorecard

Novavax, Inc. market cap: questions and answers

What is Novavax, Inc.'s market cap?

Novavax, Inc. (NVAX) has a market cap of $1.31B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.16B. That is 4.9% lower than the $1.22B of fiscal 2024.

What is the growth rate of Novavax, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 28.9% a year.

What are the highest and lowest market cap figures on record for Novavax, Inc.?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $10.64B in fiscal 2021 and the lowest $95.92M in fiscal 2019.

How is Novavax, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Novavax, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novavax, Inc. (NVAX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/NVAX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.